AI assistant
Sending…
Imunon, Inc. — Director's Dealing 2019
Nov 20, 2019
35124_dirs_2019-11-20_c6531cd6-f451-4e3b-968e-7f828dd04ec0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2019-11-20
Reporting Person: Martinez Alberto R Jr (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-11-20 | Celsion Corporation Common Stock | P | 6000 | $1.42 | Acquired | 40000 | Direct |
Footnotes
F1: The shares were purchased on the open market.
More from Imunon, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Annual Report
2026
May 4
Regulatory Filings
2026
May 4
Proxy Solicitation & Information Statement
2026
May 4
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 23
Major Shareholding Notification
2026
Feb 18